358.93
2.04%
-7.46
Vorhandelsmarkt:
359.89
0.96
+0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
United Therapeutics to Present Groundbreaking Tyvaso DPI Data at PVRI 2025 Congress - StockTitan
Manchester gets offer from United Therapeutics to buy nearly 350 acres in Hackett Hill area - AOL
United Therapeutics Corporation (NASDAQ:UTHR) Doing What It Can To Lift Shares - Simply Wall St
Wedge Capital Management L L P NC Has $28.03 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Assenagon Asset Management S.A. Sells 8,067 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
USA Financial Formulas Has $307,000 Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics (NASDAQ:UTHR) Upgraded to Strong-Buy at StockNews.com - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) Short Interest Update - MarketBeat
Wedmont Private Capital Acquires Shares of 1,276 United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
UTHR: 3 Niche Biotech Stocks Redefining Innovation - StockNews.com
Burney Co. Raises Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics Co. (NASDAQ:UTHR) COO Sells $3,646,200.00 in Stock - MarketBeat
United Therapeutics president sells $3.65 million in stock By Investing.com - Investing.com Australia
United Therapeutics president sells $3.65 million in stock - Investing.com India
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
United Therapeutics to Present at J.P. Morgan Conference - TipRanks
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Nordea Investment Management AB - MarketBeat
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance
Here's Why United Therapeutics (UTHR) is a Strong Value Stock - Yahoo Finance
Are Medical Stocks Lagging United Therapeutics (UTHR) This Year? - Yahoo Finance
7 Best Biotech Stocks to Buy for 2025 | Investing - U.S News & World Report Money
United Therapeutics president Michael Benkowitz sells $3.55 million in stock By Investing.com - Investing.com Australia
United Therapeutics president Michael Benkowitz sells $3.55 million in stock - Investing.com India
United Therapeutics snaps up another property near Silver Spring HQ - Washington Business Journal
CWA Asset Management Group LLC Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
United Therapeutics CEO to Present Business Update at J.P. Morgan Healthcare Conference - StockTitan
JPMorgan Chase & Co. Has $69 Million Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Insider Sell: Nilda Mesa Sells Shares of United Therapeutics Corp - GuruFocus.com
Nilda Mesa Sells 255 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics president Michael Benkowitz sells $3.57 million in stock By Investing.com - Investing.com Canada
United Therapeutics director Mesa Nilda sells $90,720 in stock By Investing.com - Investing.com Nigeria
United Therapeutics director Mesa Nilda sells $90,720 in stock - Investing.com India
United Therapeutics president Michael Benkowitz sells $3.57 million in stock - Investing.com
We Ran A Stock Scan For Earnings Growth And United Therapeutics (NASDAQ:UTHR) Passed With Ease - Yahoo Finance
United Therapeutics Corporation (UTHR): Among the Cheap Healthcare Stocks to Buy Heading Into 2025 - Insider Monkey
United Therapeutics president Michael Benkowitz sells $3.6m in stock - Investing.com India
Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) COO Sells 10,000 Shares of Stock - MarketBeat
United Therapeutics president Michael Benkowitz sells $3.6m in stock By Investing.com - Investing.com UK
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term - Yahoo Finance
Here are Updates on United Therapeutics Corp. (UTHR) - MSN
Is United Therapeutics (UTHR) the Best Performing Biotech Stock in 2024? - Yahoo Finance
Principal Financial Group Inc. Has $40.31 Million Stake in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term - Yahoo Finance
Insider Sell: Louis Sullivan Sells 26,209 Shares of United Thera - GuruFocus.com
United Therapeutics Co. (NASDAQ:UTHR) Director Sells $9,781,722.98 in Stock - MarketBeat
United Therapeutics director sells shares worth $9.78 million - Investing.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):